Amgen Plays Both Sides As It Builds Out Inflammation Biosimilars

Remicade Biosimilar Avsola Launched In July

 
• By Dean Rudge
  
chess
Amgen's biosimilar strategy was to embed products in its existing teams • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products